Fertility Preservation in EIN/CAH
Fertility Preservation in EIN/CAH and Grade 1/2 endometrial Cancer
Shitanshu Uppal
Publications Update # 54
The investment answer, surrogate endpoints in oncology, GOG-279 and A18 in cervical cancer
GOG 279: Cisplatin, Gemcitabine, and IMRT for Locally Advanced Vulvar Carcinoma
Weekly Cisplatin and Gemcitabine concurrent with IMRT improved CPR in women with locally advanced vulvar squamous cell carcinoma not amenable to surgical resection.
Surgical Management of Complex Endometrial Hyperplasia/EIN
Surgical Management of EIN/CAH
GOG 261: Paclitaxel and Carboplatin Versus Paclitaxel and Ifosfamide in Carcinosarcoma
Carboplatin/Taxol is not inferior to Ifos/Taxol in terms of OS and significantly increases PFS, making it a new standard treatment for carcinosarcoma
Publications Update # 53
HER-2 testing in gynecologic cancers, prognostic role of ITCs in low-grade endometrial cancer, primary cytoreduction in ovarian cancer.
Climate - GYOEDU.org
Read more on how Stripe helps GYOEDU contribute towards carbon
Publications Update # 52
Becoming G.O.A.T by adopting a goat's mentality, 3+3 clinical trial design, vulvar cancer groin node management and the risk of ovarian metastasis in endometrial cancer patients less than 50
Publications Update # 51
CALLA trial, Keynote-A18, myoinvasive or non-myoinvasive p53 abn stage 1A endometrial cancer and the effect of isolation on humans
KEYNOTE A18: Pembrolizumab Plus Chemoradiotherapy for High-Risk Locally Advanced Cervical Cancer
Pembrolizumab combined with chemoradiotherapy and then continued post-chemoradiotherapy demonstrates significant improvements in progression-free survival compared to chemoradiotherapy alone